Butoconazole vs. miconazole. European clinical experience
Journal of Reproductive Medicine 31(7 Suppl.): 660-661
In a double-blind, multicentre study, patients (n=130) were randomly assigned to a 6-d regimen of treatment with either 1% (n=44) or 2% (n=45) butoconazole nitrate or 2% miconazole (n=41) vaginal cream. Criteria for admission into the study were presence of clinical signs and/or symptoms of vaginal yeast infection, confirmed by wet smear and Candida culture in healthy, nonpregnant women.